Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
52.89
-1.45 (-2.67%)
At close: Jun 20, 2025, 2:57 PM CST
42.98%
Market Cap 6.33B
Revenue (ttm) 685.51M
Net Income (ttm) 133.74M
Shares Out 119.77M
EPS (ttm) 1.11
PE Ratio 47.48
Forward PE 39.71
Dividend 0.80 (1.47%)
Ex-Dividend Date Jan 24, 2025
Volume 1,615,850
Average Volume 2,359,316
Open 54.24
Previous Close 54.34
Day's Range 52.80 - 54.63
52-Week Range 31.30 - 61.50
Beta 0.81
RSI 48.16
Earnings Date Aug 29, 2025

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2024, Acrobiosystems's revenue was 645.02 million, an increase of 18.65% compared to the previous year's 543.65 million. Earnings were 123.83 million, a decrease of -19.38%.

Financial Statements

News

There is no news available yet.